Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
This piece explains why index fund performance changes over time and what factors investors should monitor for better outcomes.
27,966 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Citadel Securities invests $600 million across two rival crypto exchanges, Crypto.com and Kraken, valuing each at $20...
Six days after listing, a buyer snaps $4.8 million for a Medina luxury home next to Bill Gates’ Xanadu 2.0, underscor...
AI disruption is reshaping entry-level jobs, pushing the next generation to consider space-based careers. This report...
A new forecast puts Europe’s biggest economies on track for more than $600 billion in heat-driven losses by 2030, for...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
A retiree outlines a disciplined six-position income plan—three bond ETFs and three high-yield equities—to generate $...
Investors chasing a SpaceX IPO windfall risk turning luck into poor strategy. Experts warn the real lesson is risk ma...
In a hypothetical timeline for risk analysis, the death of the iranian supreme leader in a major attack sparks immedi...
Bitcoin fell to the $75,000 area after a volatile week of gains and selling. On-chain flows, high-profile bets, and F...
As retirement checks begin, a rising share of households worry about debts that survive into retirement. The IRS can ...
A Switzerland-registered firm launches the $BANK token on Solana, offering on-chain exposure to a professionally mana...